Turn Therapeutics Inc. (TTRX) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 11.45M | 5.2M | 3.29M | 3.39M |
| Cash & Short-Term Investments | 11.22M | 5.08M | 3.11M | 3.19M |
| Cash Only | 11.22M | 5.08M | 3.11M | 3.19M |
| Short-Term Investments | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - |
| Other Current Assets | 235.17K | 0 | 188.58K | 204.02K |
| Total Non-Current Assets | 7.19M | 6.97M | 1.06M | 937.34K |
| Property, Plant & Equipment | 67.57K | 0 | 89.42K | 99.99K |
| Fixed Asset Turnover | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 |
| Intangible Assets | 919.95K | 922.17K | 904.88K | 828.77K |
| Long-Term Investments | 0 | 0 | 52.7K | 0 |
| Other Non-Current Assets | 6.2M | 6.04M | 8.58K | 8.58K |
| Total Assets | 18.64M | 12.16M | 4.35M | 4.33M |
| Asset Turnover | - | - | - | - |
| Asset Growth % | - | - | - | - |
| Total Current Liabilities | 5.13M | 6M | 2.31M | 1.06M |
| Accounts Payable | 2.32M | 2.93M | 2.26M | 0 |
| Days Payables Outstanding | 16.33K | 16.88K | 15.23K | - |
| Short-Term Debt | 47.8K | 0 | 44.83K | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 2.77M | 3.03M | 0 | 1.02M |
| Current Ratio | 2.23x | 0.87x | 1.43x | 3.20x |
| Quick Ratio | 2.23x | 0.87x | 1.43x | 3.20x |
| Cash Conversion Cycle | - | - | - | - |
| Total Non-Current Liabilities | 7.4M | 1.47M | 1.48M | 1.5M |
| Long-Term Debt | 5.94M | 0 | 0 | 0 |
| Capital Lease Obligations | 21.54K | 34.08K | 46.34K | 58.04K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 |
| Total Liabilities | 12.53M | 7.48M | 3.79M | 2.56M |
| Total Debt | 6.01M | 80.38K | 91.17K | 101.45K |
| Net Debt | -5.21M | -5M | -3.01M | -3.09M |
| Debt / Equity | 0.98x | 0.02x | 0.16x | 0.06x |
| Debt / EBITDA | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - |
| Interest Coverage | - | - | - | - |
| Total Equity | 6.12M | 4.69M | 556.72K | 1.77M |
| Equity Growth % | - | - | - | - |
| Book Value per Share | 0.21 | 0.16 | 0.02 | 0.13 |
| Total Shareholders' Equity | 6.12M | 4.69M | 556.72K | 1.77M |
| Common Stock | 2.98K | 2.94K | 2.8K | 1.4K |
| Retained Earnings | -23.36M | -22.39M | -22.67M | -20.76M |
| Treasury Stock | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 |